Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024

Advances in Nanotechnology-Based Drug Delivery Systems in the Treatment of Hepatocellular Carcinoma.

View Full Paper
Ask AI
Bookmark
Share

Authors

SYSenlin YangYXYang XiangYYYijun Yang

Discussion

Loading...

Member takes

Overview

Review demonstrates nanoparticle drug delivery systems improve targeting in hepatocellular carcinoma, suggesting alternatives to conventional non-surgical therapies.

Key Points

  • Hepatocellular carcinoma accounts for more than 90% of primary liver cancer cases, but late-stage diagnosis frequently prevents successful outcomes from surgical resection.
  • Assessment of nano-delivery systems demonstrates that nanoparticles provide high surface areas and tunable features to transport therapeutic cytokines and genetic drugs.
  • Nanotechnology-based drug delivery systems may resolve the low tumor selectivity and severe side effects of non-surgical regimens in advanced hepatocellular carcinoma.

Cite This Study

Yang et al. (2024) studied this question.

synapsesocial.com/papers/68e673edb6db6435875fe0cfhttps://doi.org/10.3881/j.issn.1000-503x.15669
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nanoscale Delivery Systems for Hepatocellular Carcinoma: Functionalization, Delivery Strategies, and Clinical Challenges2026 · 3 citations
  2. 2Emerging nanomedicine strategies for hepatocellular carcinoma therapy2024 · 2 citations
  3. 3Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment2024 · 1 citations
  4. 4Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy2024 · 16 citations
  5. 5Recent advances in hepatocellular carcinoma-targeted nanoparticles2024 · 3 citations